<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05065528</url>
  </required_header>
  <id_info>
    <org_study_id>EGME#01-2021</org_study_id>
    <nct_id>NCT05065528</nct_id>
  </id_info>
  <brief_title>Mag Con: Efficacy of Oral Mag. in Acute Concussion in Adolescents</brief_title>
  <official_title>A Randomized Trial Evaluating the Efficacy of Oral Magnesium in Symptomatic Reduction of Acute Concussion in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health - Lakeland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spectrum Health - Lakeland</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized trial will compare the clinical efficacy of oral magnesium oxide,&#xD;
      acetaminophen and ondansetron, to that of PO acetaminophen and ondansetron in the treatment&#xD;
      of adolescents presenting within 48 hours of a mild traumatic brain injury. Our primary&#xD;
      endpoint will be to evaluate if magnesium has an impact on patient's Post-Concussion Symptom&#xD;
      Severity Score Index.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison between treatment and placebo</measure>
    <time_frame>3 days</time_frame>
    <description>comparison between the treatment and placebo groups in their symptom severity scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse effect related to medication administration</measure>
    <time_frame>72 hours</time_frame>
    <description>development of adverse effects related to medication administration, need for further intervention in the emergency department, whether they have returned to their baseline function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Concussion, Mild</condition>
  <condition>Traumatic Brain Injury, Mild</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Magnesium</intervention_name>
    <description>Will receive symptomatic care along with 400 mg supplemental magnesium twice daily for 3 days</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 12 to 18 years; presenting chief complaint of headache, head injury, or concussion&#xD;
             within the first 48 hours of injury; GCS &gt; 13 on arrival&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt; 12 years or &gt; 18 years; inability to provide informed consent; vomiting &gt; 2&#xD;
             episodes following injury; physical or mental disability hindering adequate response&#xD;
             to assessment of symptoms; hemodynamic instability/medical condition requiring further&#xD;
             acute life-saving medical intervention; known brain mass, intracranial hemorrhage,&#xD;
             skull fracture; known contraindications to magnesium use; known contraindications to&#xD;
             ondansetron use; pregnant patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jasmine Collard</last_name>
    <phone>2699854562</phone>
    <email>jasmine.collard@spectrumhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Spectrum Health Lakeland</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Collard</last_name>
      <phone>269-985-4562</phone>
      <email>jasmine.collard@spectrumhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

